Hanmi Financial Corp
HAFCHanmi Financial Corp (HAFC) is a bank holding company headquartered in Los Angeles, California. It operates through its subsidiary, Hanmi Bank, which provides a range of banking services including commercial banking, real estate lending, and retail banking to small and mid-sized businesses, professionals, and individual customers. Hanmi Financial is known for its focus on personalized service and its strong presence in the California market.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 20, 2026 | $0.28 | 2026-05-04 | 2026-05-04 |
| February 26, 2026 | $0.28 | 2026-02-09 | 2026-02-09 |
| November 20, 2025 | $0.27 | 2025-11-04 | 2025-11-04 |
| August 20, 2025 | $0.27 | 2025-08-04 | 2025-08-04 |
| May 21, 2025 | $0.27 | 2025-05-05 | 2025-05-05 |
Dividends Summary
- Consistent Payer: Hanmi Financial Corp has rewarded shareholders with 71 dividend payments over the past 22 years.
- Total Returned Value: Investors who held HAFC shares during this period received a total of $11.18 per share in dividend income.
- Latest Payout: The most recent dividend of $0.28/share was paid 59 days ago, on May 20, 2026.
- Yield & Schedule: HAFC currently pays dividends quarterly with an annual yield of 3.37%.
- Dividend Growth: Since 2004, the dividend payout has grown by 180.0%, from $0.10 to $0.28.
- Dividend Reliability: HAFC has maintained or increased its dividend for 24 consecutive payments.
Company News
Hanmi Financial Corporation (NASDAQ: HAFC) announced that its Board of Directors declared a cash dividend of $0.28 per share for the 2026 second quarter, payable on May 20, 2026, to stockholders of record as of May 4, 2026. The Los Angeles-based bank operates 32 full-service branches across nine states and specializes in real estate, commercial, ...
Hanmi Financial Corporation announced a 4% increase in its quarterly cash dividend to $0.28 per share and expanded its share repurchase authorization by 1.5 million shares to approximately 2.3 million shares total. The moves reflect the company's confidence in its financial strength following strong 2025 earnings growth and disciplined execution.
The global automated pharmacy compounding systems market is projected to grow from USD 2.95 billion in 2025 to USD 5.27 billion by 2035, driven by the need to reduce medication errors, demand for personalized medicine, and stringent regulatory standards.
Aptose Biosciences reported promising results for tuspetinib in treating newly diagnosed acute myeloid leukemia (AML), with 100% complete response rates at higher dose levels and plans to present updated data at the ASH Annual Meeting in December 2025.
Hanmi Financial Corporation announced a cash dividend of $0.27 per share for the 2025 fourth quarter, payable on November 20, 2025, to stockholders of record as of November 4, 2025.
